Listen to Medscape InDiscussion: Breast Cancer and HER2, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1001124. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
All content for Medscape InDiscussion: Breast Cancer and HER2 is the property of Medscape and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Listen to Medscape InDiscussion: Breast Cancer and HER2, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1001124. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
New Classification of HER2–Ultra-Low Breast Cancer: What Do We Need to Know?
Medscape InDiscussion: Breast Cancer and HER2
17 minutes 20 seconds
11 months ago
New Classification of HER2–Ultra-Low Breast Cancer: What Do We Need to Know?
Medscape InDiscussion: Breast Cancer and HER2
Listen to Medscape InDiscussion: Breast Cancer and HER2, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1001124. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
